we have examined da sensitivity in 17 women with ih and 19 female controls by evaluating the plasma prl responses to successive infusions of increasing concentrations of da ( 4 , 40 , and 400 ng/kg . min ) as well as to a dopaminergic agonist , bromocriptine ( 2.5 mg , orally ) , and to a dopaminergic agonist , bromocriptine ( 2.5 mg , orally ) , and to a dopaminergic receptor blocker , domperidone ( 2 mg , iv ) .
C0013030
da
C0282151
dopaminergic